AAPL281.62-2.17 (-0.76%) ▼|ABBV253.74+0.39 (+0.15%) ▲|ABT93.48-0.64 (-0.68%) ▼|ACN125.21-3.77 (-2.92%) ▼|ADBE205.52+2.79 (+1.38%) ▲|AMAT697.81+70.97 (+11.32%) ▲|AMD537.18+15.60 (+2.99%) ▲|AMGN359.53+1.20 (+0.33%) ▲|AMT169.07-6.52 (-3.71%) ▼|AMZN240.98+8.29 (+3.56%) ▲|AVGO375.57+10.55 (+2.89%) ▲|AXP341.59+1.23 (+0.36%) ▲|BA215.39-1.86 (-0.86%) ▼|BAC58.12+0.24 (+0.41%) ▲|BKNG183.41+1.95 (+1.07%) ▲|BLK953.48-11.23 (-1.16%) ▼|BMY57.68+0.16 (+0.28%) ▲|BNY144.55+0.99 (+0.69%) ▲|BRK-B496.38-2.28 (-0.46%) ▼|C143.43+1.67 (+1.17%) ▲|CAT1,030.95+33.48 (+3.36%) ▲|CL91.54-0.53 (-0.58%) ▼|CMCSA24.60+1.43 (+6.17%) ▲|COF203.27-0.73 (-0.36%) ▼|COP104.98-0.99 (-0.93%) ▼|COST944.63-7.91 (-0.83%) ▼|CRM158.08-0.29 (-0.18%) ▼|CSCO117.87+4.10 (+3.60%) ▲|CVS103.62-0.72 (-0.69%) ▼|CVX169.70-1.36 (-0.80%) ▼|DE616.09+2.85 (+0.46%) ▲|DHR192.02-4.17 (-2.13%) ▼|DIS98.89+0.10 (+0.10%) ▲|DUK127.92-0.48 (-0.37%) ▼|EMR142.90-0.60 (-0.41%) ▼|FDX324.30+5.77 (+1.81%) ▲|GD349.37+2.66 (+0.77%) ▲|GE373.19+4.19 (+1.13%) ▲|GEV1,103.00+57.83 (+5.53%) ▲|GILD125.85-2.03 (-1.59%) ▼|GM78.28+0.18 (+0.23%) ▲|GOOG351.10+16.41 (+4.90%) ▲|GOOGL353.10+15.71 (+4.66%) ▲|GS1,025.85+6.24 (+0.61%) ▲|HD349.50+0.64 (+0.18%) ▲|HON236.93-6.49 (-2.66%) ▼|IBM276.12+4.49 (+1.65%) ▲|INTC130.75+2.43 (+1.89%) ▲|INTU267.01-0.72 (-0.27%) ▼|ISRG407.62+3.35 (+0.83%) ▲|JNJ256.32+1.66 (+0.65%) ▲|JPM331.28+2.23 (+0.68%) ▲|KO82.24-0.40 (-0.48%) ▼|LIN509.98-9.64 (-1.86%) ▼|LLY1,219.25+11.13 (+0.92%) ▲|LMT505.29-2.11 (-0.42%) ▼|LOW220.59-1.89 (-0.85%) ▼|LRCX410.91+31.82 (+8.39%) ▲|MA511.37+12.35 (+2.47%) ▲|MCD267.39-2.38 (-0.88%) ▼|MDLZ59.84-0.95 (-1.56%) ▼|MDT81.29+0.31 (+0.38%) ▲|META565.86+15.61 (+2.84%) ▲|MMM163.37-0.65 (-0.39%) ▼|MO73.31-0.48 (-0.65%) ▼|MRK128.43-0.23 (-0.18%) ▼|MS213.93+1.90 (+0.89%) ▲|MSFT369.26-3.71 (-0.99%) ▼|MU1,114.47-17.87 (-1.58%) ▼|NEE87.92-0.64 (-0.72%) ▼|NFLX74.32+0.51 (+0.69%) ▲|NKE41.47+0.72 (+1.75%) ▲|NOW100.20+1.86 (+1.89%) ▲|NVDA194.17+1.64 (+0.85%) ▲|ORCL148.58+0.05 (+0.03%) ▲|PEP137.89-3.50 (-2.48%) ▼|PFE24.25-0.04 (-0.16%) ▼|PG147.25-1.77 (-1.19%) ▼|PLTR116.62+3.69 (+3.26%) ▲|PM180.32-0.46 (-0.25%) ▼|QCOM191.17+1.78 (+0.94%) ▲|RTX188.08+0.09 (+0.05%) ▲|SBUX104.23-0.38 (-0.36%) ▼|SCHW90.61-0.06 (-0.07%) ▼|SO96.58-0.58 (-0.60%) ▼|SPG227.21+0.32 (+0.14%) ▲|T21.78-0.94 (-4.15%) ▼|TMO502.85-10.18 (-1.98%) ▼|TMUS175.40-7.28 (-3.99%) ▼|TSLA409.28+29.57 (+7.79%) ▲|TXN289.81+4.39 (+1.54%) ▲|UBER75.02-1.18 (-1.55%) ▼|UNH417.51-10.38 (-2.43%) ▼|UNP270.30+1.95 (+0.73%) ▲|UPS107.70-0.44 (-0.41%) ▼|USB61.31+0.40 (+0.66%) ▲|V341.90+5.67 (+1.69%) ▲|VZ43.85-2.69 (-5.78%) ▼|WFC84.09+0.23 (+0.27%) ▲|WMT114.36-1.33 (-1.15%) ▼|XOM136.74+0.20 (+0.15%) ▲|AAPL281.62-2.17 (-0.76%) ▼|ABBV253.74+0.39 (+0.15%) ▲|ABT93.48-0.64 (-0.68%) ▼|ACN125.21-3.77 (-2.92%) ▼|ADBE205.52+2.79 (+1.38%) ▲|AMAT697.81+70.97 (+11.32%) ▲|AMD537.18+15.60 (+2.99%) ▲|AMGN359.53+1.20 (+0.33%) ▲|AMT169.07-6.52 (-3.71%) ▼|AMZN240.98+8.29 (+3.56%) ▲|AVGO375.57+10.55 (+2.89%) ▲|AXP341.59+1.23 (+0.36%) ▲|BA215.39-1.86 (-0.86%) ▼|BAC58.12+0.24 (+0.41%) ▲|BKNG183.41+1.95 (+1.07%) ▲|BLK953.48-11.23 (-1.16%) ▼|BMY57.68+0.16 (+0.28%) ▲|BNY144.55+0.99 (+0.69%) ▲|BRK-B496.38-2.28 (-0.46%) ▼|C143.43+1.67 (+1.17%) ▲|CAT1,030.95+33.48 (+3.36%) ▲|CL91.54-0.53 (-0.58%) ▼|CMCSA24.60+1.43 (+6.17%) ▲|COF203.27-0.73 (-0.36%) ▼|COP104.98-0.99 (-0.93%) ▼|COST944.63-7.91 (-0.83%) ▼|CRM158.08-0.29 (-0.18%) ▼|CSCO117.87+4.10 (+3.60%) ▲|CVS103.62-0.72 (-0.69%) ▼|CVX169.70-1.36 (-0.80%) ▼|DE616.09+2.85 (+0.46%) ▲|DHR192.02-4.17 (-2.13%) ▼|DIS98.89+0.10 (+0.10%) ▲|DUK127.92-0.48 (-0.37%) ▼|EMR142.90-0.60 (-0.41%) ▼|FDX324.30+5.77 (+1.81%) ▲|GD349.37+2.66 (+0.77%) ▲|GE373.19+4.19 (+1.13%) ▲|GEV1,103.00+57.83 (+5.53%) ▲|GILD125.85-2.03 (-1.59%) ▼|GM78.28+0.18 (+0.23%) ▲|GOOG351.10+16.41 (+4.90%) ▲|GOOGL353.10+15.71 (+4.66%) ▲|GS1,025.85+6.24 (+0.61%) ▲|HD349.50+0.64 (+0.18%) ▲|HON236.93-6.49 (-2.66%) ▼|IBM276.12+4.49 (+1.65%) ▲|INTC130.75+2.43 (+1.89%) ▲|INTU267.01-0.72 (-0.27%) ▼|ISRG407.62+3.35 (+0.83%) ▲|JNJ256.32+1.66 (+0.65%) ▲|JPM331.28+2.23 (+0.68%) ▲|KO82.24-0.40 (-0.48%) ▼|LIN509.98-9.64 (-1.86%) ▼|LLY1,219.25+11.13 (+0.92%) ▲|LMT505.29-2.11 (-0.42%) ▼|LOW220.59-1.89 (-0.85%) ▼|LRCX410.91+31.82 (+8.39%) ▲|MA511.37+12.35 (+2.47%) ▲|MCD267.39-2.38 (-0.88%) ▼|MDLZ59.84-0.95 (-1.56%) ▼|MDT81.29+0.31 (+0.38%) ▲|META565.86+15.61 (+2.84%) ▲|MMM163.37-0.65 (-0.39%) ▼|MO73.31-0.48 (-0.65%) ▼|MRK128.43-0.23 (-0.18%) ▼|MS213.93+1.90 (+0.89%) ▲|MSFT369.26-3.71 (-0.99%) ▼|MU1,114.47-17.87 (-1.58%) ▼|NEE87.92-0.64 (-0.72%) ▼|NFLX74.32+0.51 (+0.69%) ▲|NKE41.47+0.72 (+1.75%) ▲|NOW100.20+1.86 (+1.89%) ▲|NVDA194.17+1.64 (+0.85%) ▲|ORCL148.58+0.05 (+0.03%) ▲|PEP137.89-3.50 (-2.48%) ▼|PFE24.25-0.04 (-0.16%) ▼|PG147.25-1.77 (-1.19%) ▼|PLTR116.62+3.69 (+3.26%) ▲|PM180.32-0.46 (-0.25%) ▼|QCOM191.17+1.78 (+0.94%) ▲|RTX188.08+0.09 (+0.05%) ▲|SBUX104.23-0.38 (-0.36%) ▼|SCHW90.61-0.06 (-0.07%) ▼|SO96.58-0.58 (-0.60%) ▼|SPG227.21+0.32 (+0.14%) ▲|T21.78-0.94 (-4.15%) ▼|TMO502.85-10.18 (-1.98%) ▼|TMUS175.40-7.28 (-3.99%) ▼|TSLA409.28+29.57 (+7.79%) ▲|TXN289.81+4.39 (+1.54%) ▲|UBER75.02-1.18 (-1.55%) ▼|UNH417.51-10.38 (-2.43%) ▼|UNP270.30+1.95 (+0.73%) ▲|UPS107.70-0.44 (-0.41%) ▼|USB61.31+0.40 (+0.66%) ▲|V341.90+5.67 (+1.69%) ▲|VZ43.85-2.69 (-5.78%) ▼|WFC84.09+0.23 (+0.27%) ▲|WMT114.36-1.33 (-1.15%) ▼|XOM136.74+0.20 (+0.15%) ▲|
30.5 C
New York
Monday, June 29, 2026

Tag: programs

newssourceFORcompanyinformationcontent1releasesmarket

Avis Budget Group Reports Second Quarter Results

PARSIPPANY, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced financial results for second quarter 2025 today. We ended the quarter with revenues of $3.0 billion, net income of $5 million, and Adjusted EBITDA1 of $277 million.

BlueSphere Bio CSO Alan Korman Recipient of Esteemed 2025 William B. Coley Award

Alan Korman honored in the category of tumor immunology for foundational role in checkpoint inhibitors PITTSBURGH, July 29, 2025 /PRNewswire/ -- BlueSphere Bio, a clinical...

Shopoff Realty Investments Named One of the 2025 Best Places to Work in Orange County

IRVINE, Calif., July 29, 2025 /PRNewswire/ -- Shopoff Realty Investments ("Shopoff"), a national manager of opportunistic and value-add real estate investments, was recently named one of...

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%

Milan, 29th July 2025 – The Board of Directors of Recordati S.p.A. approved the interim financial statements as of June 30, 2025, pursuant to Art. 154-ter of Italian Legislative Decree 58/1998 and subsequent amendments, prepared in accordance with said Decree and the CONSOB Issuers Regulation. The statements were prepared in accordance with International Accounting Standard (IAS) 34 requirements for interim reporting, based on the assessment, measurement and recognition criteria set by the IFRSs. The interim financial statements on June 30, 2025 – as well as the Independent Auditors’ report on such statements - will be available within the legal deadline at the company’s offices and on the company’s website (www.recordati.com) and can also be viewed on the authorized storage system 1Info(www.1Info.it).

Info-Tech LIVE 2025 in Barcelona Reveals First Round of Featured Speakers

Building on its initial announcement, Info-Tech Research Group, a global IT research and advisory firm, has announced the first round of featured speakers for...

Info-Tech LIVE 2025 in Barcelona Reveals First Round of Featured Speakers

Building on its initial announcement, Info-Tech Research Group, a global IT research and advisory firm, has announced the first round of featured speakers for...

Back to School Summer Sleep Slide? Dr. Bedtime’s Book Gets Children Back On Track

SAN JOSE, Calif., July 29, 2025 /PRNewswire/ -- The Sleep to Live Well Foundation (STLW) announces the launch of its enchanting new children's book,...

Info-Tech LIVE 2025 in Barcelona Reveals First Round of Featured Speakers

Building on its initial announcement, Info-Tech Research Group, a global IT research and advisory firm, has announced the first round of featured speakers for...

Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa

KIGALI, Rwanda and SAN FRANCISCO and AUBAGNE, France, July 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius Stedim Biotech, a global partner of biopharmaceutical manufacturing, have announced a partnership to accelerate Africa’s biopharmaceutical industry and address the continent’s urgent, dual health burdens in infectious and non-communicable diseases.

Digital Rights Management Market worth $11.05 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., July 29, 2025 /PRNewswire/ -- According to MarketsandMarkets™, the Digital Rights Management Market is estimated to be USD 6.72 billion in...

Future is Bright for Academic Partnership Program at Canada’s National Nuclear Laboratory as Universities Agree to Five-Year Extensions

Innovative academic program contributes to a strong and sustainable talent pipeline for Canada’s national nuclear laboratories and Canadian nuclear sector 
Innovative academic program contributes to a strong and sustainable talent pipeline for Canada’s national nuclear laboratories and Canadian nuclear sector

Former AdventHealth President & CEO Terry Shaw Joins RAAPID Advisory Board

LOUISVILLE, Ky., July 29, 2025 /PRNewswire/ -- RAAPID, a M12 (Microsoft Venture Fund) backed company and leading AI-powered risk adjustment solutions provider, today announced the...

Cyberhaven Transforms Enterprise Data Security with Reimagined DLP and Insider Threat Platform

Revolutionary approach delivers 90% fewer false positives and 5x faster incident investigations MOUNTAIN VIEW, Calif., July 29, 2025 /PRNewswire/ -- Cyberhaven, the leader in AI-powered...

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

Therini Bio announced the dosing of the first patient in their Phase 1b trial evaluating THN391 in Alzheimer's Disease

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPrograms

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers